The death of 254 women from poor families from villages and slums in India, who were participants in US-funded clinical trials for cervical cancer, has triggered public outrage about the ethics of how clinical trials are conducted in India. The women who died were part of a control group who were kept without screening to study death rates in unscreened populations.
